VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PFE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PFEPfizer Inc.
$24.07$136.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPFEQuarterly Financials

Pfizer Inc. (PFE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Pfizer Inc. (PFE) quarterly income statement — complete revenue, gross profit & net income history

PFE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue14.45B17.56B16.65B14.65B13.71B17.76B17.7B13.28B14.88B14.57B13.49B13.01B18.49B24.29B22.64B27.74B25.66B23.84B24.04B18.9B
Revenue Growth %5.37%-1.16%-5.92%10.31%-7.82%21.91%31.21%2.12%-19.51%-40.02%-40.41%-53.11%-27.96%1.9%-5.81%46.79%76.78%104.9%133.87%91.6%
Cost of Goods Sold4.73B5.27B4.17B5.23B3.89B4.79B6.93B5.04B4.38B8.59B10.6B4.59B5.95B10.9B6.99B9.07B10.8B10.68B10.86B7.84B
COGS % of Revenue32.74%30.03%25.05%35.71%28.35%26.99%39.15%37.94%29.44%58.96%78.59%35.33%32.19%44.87%30.87%32.68%42.08%44.79%45.16%41.51%
Gross Profit9.72B12.29B12.48B9.42B9.83B12.97B10.77B8.24B10.5B5.98B2.89B8.41B12.54B13.39B15.65B18.68B14.86B13.16B13.18B11.05B
Gross Margin %67.26%69.97%74.95%64.29%71.65%73.01%60.85%62.06%70.56%41.04%21.41%64.67%67.81%55.13%69.13%67.32%57.92%55.21%54.84%58.49%
Gross Profit Growth %-1.09%-5.27%15.89%14.28%-6.39%116.86%272.96%-2.01%-16.26%-55.34%-81.55%-54.96%-15.66%1.75%18.73%68.95%56.16%65.68%77.6%53.91%
Operating Expenses5.69B8.6B8.93B5.84B5.2B7.24B5.8B6.36B5.94B7.24B5.89B6.06B5.85B8.04B5.95B5.73B4.82B9.88B5.43B5.07B
OpEx % of Revenue39.36%48.97%53.63%39.89%37.94%40.78%32.78%47.91%39.92%49.71%43.69%46.6%31.65%33.11%26.28%20.65%18.78%41.45%22.59%26.81%
Selling, General & Admin2.96B3.73B3.19B3.4B3.02B4.23B3.24B3.69B3.46B4.47B3.21B3.43B3.36B4.43B3.25B2.91B2.52B3.96B2.75B2.83B
SG&A % of Revenue20.49%21.27%19.13%23.22%22.05%23.79%18.29%27.76%23.25%30.68%23.81%26.39%18.16%18.23%14.37%10.5%9.82%16.63%11.44%14.96%
Research & Development2.63B3.42B3.94B2.44B2.18B3.02B2.56B2.68B2.48B2.77B2.68B2.63B2.49B3.62B2.7B2.81B2.3B5.92B2.68B2.24B
R&D % of Revenue18.18%19.47%23.63%16.67%15.89%16.98%14.49%20.15%16.67%19.03%19.88%20.21%13.49%14.88%11.91%10.15%8.97%24.81%11.15%11.85%
Other Operating Expenses1000K1000K1000K00000000000000000
Operating Income4.03B3.69B3.55B3.58B4.62B5.72B4.97B1.88B4.56B-1.26B-3.01B2.35B6.68B5.35B9.7B12.95B10.04B3.28B7.75B5.99B
Operating Margin %27.9%21.01%21.32%24.4%33.71%32.23%28.06%14.15%30.64%-8.67%-22.28%18.07%36.16%22.02%42.84%46.67%39.14%13.76%32.24%31.68%
Operating Income Growth %-12.8%-35.58%-28.54%90.26%1.43%553.29%265.27%-20.08%-31.8%-123.62%-130.99%-81.84%-33.44%63.05%25.15%116.22%108.75%256.13%210%138.47%
EBITDA5.21B5.38B5.21B5.2B6.24B7.52B6.72B3.61B6.29B407M-1.45B3.92B8.17B6.87B10.88B14.12B11.23B4.56B9.09B7.3B
EBITDA Margin %36.09%30.61%31.3%35.49%45.51%42.31%37.98%27.18%42.31%2.79%-10.72%30.17%44.21%28.27%48.07%50.9%43.76%19.12%37.82%38.61%
EBITDA Growth %-16.45%-28.49%-22.48%44.04%-0.84%1746.68%564.94%-8%-22.97%-94.07%-113.29%-72.21%-27.23%50.69%19.7%93.56%86.61%124.59%145.17%96.66%
D&A (Non-Cash Add-back)1.18B1.69B1.66B1.63B1.62B1.79B1.75B1.73B1.74B1.67B1.56B1.57B1.49B1.52B1.18B1.18B1.19B1.28B1.34B1.31B
EBIT4.03B-931M3.99B3.7B3.44B3.35B5.5B674M4.21B-3.44B-2.66B2.78B6.59B5.54B9.31B11.74B9.37B4.14B8.17B7.26B
Net Interest Income-554M-545M-514M-498M-511M-569M-667M-648M-661M-80M-172M-192M-141M-176M-241M-263M-308M-301M-315M-303M
Interest Income115M166M138M156M143M170M116M130M129M609M523M316M177M137M70M30M14M14M10M13M
Interest Expense668M711M652M654M654M739M783M778M790M689M695M508M318M313M311M293M322M315M325M316M
Other Income/Expense-862M-5.33B-216M-531M-1.84B-5.74B-253M-1.98B-1.14B-2.87B-346M-82M-415M-117M-698M-1.5B-993M547M93M961M
Pretax Income3.17B-1.64B3.33B3.04B2.78B-10M4.71B-103M3.42B-4.13B-3.35B2.27B6.27B5.23B9B11.45B9.05B3.83B7.84B6.95B
Pretax Margin %21.94%-9.35%20.02%20.77%20.3%-0.06%26.64%-0.78%22.99%-28.34%-24.85%17.44%33.92%21.54%39.76%41.26%35.27%16.05%32.63%36.77%
Income Tax461M-2M-216M141M-189M-421M234M-134M293M-794M-964M-71M715M230M356M1.57B1.17B249M-328M1.12B
Effective Tax Rate %14.54%0.12%-6.48%4.63%-6.79%4210%4.96%130.1%8.56%19.23%28.76%-3.13%11.4%4.4%3.96%13.72%12.95%6.51%-4.18%16.16%
Net Income2.69B-1.65B3.54B2.91B2.97B403M4.47B24M3.12B-3.34B-2.39B2.33B5.54B4.99B8.63B9.87B7.87B3.39B8.16B5.8B
Net Margin %18.6%-9.39%21.26%19.86%21.63%2.27%25.27%0.18%20.97%-22.94%-17.75%17.91%29.98%20.56%38.12%35.58%30.68%14.23%33.95%30.68%
Net Income Growth %-9.4%-508.93%-20.84%12025%-4.9%112.05%286.84%-98.97%-43.7%-166.95%-127.74%-76.41%-29.61%47.16%5.77%70.22%61.43%300.59%455.41%66.21%
Net Income (Continuing)2.71B-1.64B3.55B2.9B2.97B411M4.48B31M3.13B-3.33B-2.39B2.34B5.55B5B8.64B9.88B7.88B3.58B8.17B5.83B
Discontinued Operations-1000K001000K0000000000000-1000K00
Minority Interest303M299M295M317M299M294M272M275M276M274M270M274M266M256M259M261M261M262M275M273M
EPS (Diluted)0.47-0.290.620.510.520.070.780.000.55-0.60-0.420.410.970.871.511.731.370.591.431.02
EPS Growth %-9.55%-503.34%-20.92%--5.13%112.05%284.91%-98.97%-43.4%-168.64%-128.1%-76.41%-29.23%47.75%5.89%69.23%58.73%293.25%446.47%64.49%
EPS (Basic)0.47-0.290.620.510.520.070.790.000.55-0.60-0.420.410.980.891.541.771.400.601.451.04
Diluted Shares Outstanding5.73B5.69B5.71B5.71B5.71B5.7B5.71B5.7B5.7B5.65B5.65B5.71B5.73B5.74B5.72B5.71B5.76B5.77B5.72B5.68B
Basic Shares Outstanding5.69B5.68B5.68B5.68B5.67B5.67B5.67B5.67B5.66B5.65B5.65B5.65B5.63B5.62B5.61B5.59B5.62B5.62B5.61B5.6B
Dividend Payout Ratio90.96%-69.02%84.02%82.14%590.57%53.21%9916.67%76.03%--99.4%41.56%44.96%26.01%22.73%28.57%64.52%26.78%37.64%